A detailed history of Sei Investments CO transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Sei Investments CO holds 186,626 shares of BIO stock, worth $49.9 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
186,626
Previous 157,266 18.67%
Holding current value
$49.9 Million
Previous $50.8 Million 27.12%
% of portfolio
0.1%
Previous 0.08%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

BUY
$304.11 - $351.99 $8.93 Million - $10.3 Million
29,360 Added 18.67%
186,626 $64.5 Million
Q4 2023

Feb 14, 2024

BUY
$269.37 - $365.04 $4.07 Million - $5.51 Million
15,094 Added 10.62%
157,266 $50.8 Million
Q3 2023

Nov 14, 2023

BUY
$350.25 - $422.63 $5.24 Million - $6.33 Million
14,972 Added 11.77%
142,172 $51 Million
Q2 2023

Aug 11, 2023

SELL
$359.49 - $486.4 $2.01 Million - $2.72 Million
-5,601 Reduced 4.22%
127,200 $48.2 Million
Q1 2023

May 12, 2023

BUY
$418.69 - $503.0 $10.3 Million - $12.4 Million
24,667 Added 22.81%
132,801 $63.6 Million
Q4 2022

Feb 10, 2023

SELL
$351.71 - $456.01 $6.54 Million - $8.48 Million
-18,590 Reduced 14.67%
108,134 $45.5 Million
Q3 2022

Nov 14, 2022

BUY
$412.59 - $563.26 $2.52 Million - $3.44 Million
6,103 Added 5.06%
126,724 $52.9 Million
Q2 2022

Aug 15, 2022

BUY
$463.67 - $597.16 $15 Million - $19.4 Million
32,420 Added 36.76%
120,621 $59.7 Million
Q1 2022

May 13, 2022

BUY
$524.57 - $735.42 $3.08 Million - $4.31 Million
5,867 Added 7.13%
88,201 $49.9 Million
Q4 2021

Feb 14, 2022

SELL
$708.84 - $794.68 $1.43 Million - $1.6 Million
-2,018 Reduced 2.39%
82,334 $62.3 Million
Q3 2021

Nov 12, 2021

BUY
$657.71 - $825.77 $44.2 Million - $55.5 Million
67,172 Added 390.99%
84,352 $62.8 Million
Q2 2021

Aug 06, 2021

BUY
$576.64 - $649.04 $450,355 - $506,900
781 Added 4.76%
17,180 $11.1 Million
Q1 2021

May 12, 2021

BUY
$547.01 - $662.35 $1.8 Million - $2.17 Million
3,283 Added 25.03%
16,399 $9.41 Million
Q4 2020

Feb 08, 2021

BUY
$510.68 - $643.45 $413,140 - $520,551
809 Added 6.57%
13,116 $7.66 Million
Q3 2020

Dec 04, 2020

SELL
$454.43 - $535.6 $862,962 - $1.02 Million
-1,899 Reduced 13.37%
12,307 $6.71 Million
Q3 2020

Nov 06, 2020

SELL
$454.43 - $535.6 $1.58 Million - $1.86 Million
-3,475 Reduced 19.65%
14,206 $7.68 Million
Q2 2020

Aug 17, 2020

BUY
$334.87 - $493.06 $298,369 - $439,316
891 Added 5.31%
17,681 $7.83 Million
Q2 2020

Aug 11, 2020

SELL
$334.87 - $493.06 $127,585 - $187,855
-381 Reduced 2.22%
16,790 $6.77 Million
Q1 2020

May 14, 2020

BUY
$320.01 - $409.07 $863,706 - $1.1 Million
2,699 Added 18.65%
17,171 $5.96 Million
Q4 2019

Feb 06, 2020

SELL
$319.73 - $374.2 $2.68 Million - $3.13 Million
-8,367 Reduced 36.63%
14,472 $5.27 Million
Q3 2019

Nov 12, 2019

BUY
$304.55 - $345.24 $1.6 Million - $1.82 Million
5,259 Added 29.91%
22,839 $7.6 Million
Q2 2019

Aug 14, 2019

SELL
$286.93 - $312.59 $171,871 - $187,241
-599 Reduced 3.3%
17,580 $5.6 Million
Q1 2019

May 15, 2019

SELL
$224.3 - $317.41 $4.33 Million - $6.13 Million
-19,323 Reduced 51.53%
18,179 $5.65 Million
Q4 2018

Feb 13, 2019

BUY
$220.1 - $309.0 $1.19 Million - $1.67 Million
5,410 Added 16.86%
37,502 $10.6 Million
Q3 2018

Nov 08, 2018

SELL
$289.28 - $326.15 $8.18 Million - $9.22 Million
-28,279 Reduced 46.84%
32,092 $10.1 Million
Q2 2018

Aug 03, 2018

BUY
$244.1 - $303.88 $14.7 Million - $18.3 Million
60,371 New
60,371 $17.4 Million
Q1 2018

May 11, 2018

SELL
$233.97 - $274.11 $21.8 Million - $25.6 Million
-93,387 Closed
0 $0
Q4 2017

Feb 08, 2018

BUY
$216.94 - $271.3 $3.88 Million - $4.85 Million
17,890 Added 23.7%
93,387 $21.9 Million
Q3 2017

Nov 06, 2017

BUY
$212.27 - $242.28 $16 Million - $18.3 Million
75,497
75,497 $16.4 Million

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $6.59B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Sei Investments CO Portfolio

Follow Sei Investments CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Sei Investments CO with notifications on news.